U.S. approves drug-resistant tuberculosis treatment from J&J

Dec 31 (Reuters) - U.S. health regulators have approved a
new Johnson & Johnson drug for patients with
tuberculosis who do not respond to other treatments, the company
said.

pellet stoves reviews pellet stoves inserts